Vitrakvi
25 mg · Capsule
- Prescription only
- Kinase Inhibitor
- Active substance
- Larotrectinib
- Made by
- Loxo Oncology, Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
Details
| Made by | Loxo Oncology, Inc. |
|---|---|
| Active substance | Larotrectinib |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 25 mg |
| Form | Capsule |
| Route | Oral |
| Packs | 60 CAPSULE in 1 BOTTLE |
| NDC | 71777-390 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
6 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Capsule4 products
25 mg2
25 mg · 2 companies
- Bayer HealthCare Pharmaceuticals Inc.
- Loxo Oncology, Inc. · this page
100 mg2
100 mg · 2 companies
- Solution, Concentrate1 products
- Solution1 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.